You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 16, 2024

PAXIL Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Paxil, and when can generic versions of Paxil launch?

Paxil is a drug marketed by Apotex and is included in four NDAs.

The generic ingredient in PAXIL is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.

US Patents and Regulatory Information for PAXIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-001 Oct 9, 1998 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-002 Dec 29, 1992 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-004 Oct 9, 1998 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL CR paroxetine hydrochloride TABLET, EXTENDED RELEASE;ORAL 020936-002 Feb 16, 1999 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-003 Dec 29, 1992 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-002 Oct 9, 1998 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PAXIL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-001 Dec 29, 1992 ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-001 Oct 9, 1998 ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-001 Dec 29, 1992 ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-001 Oct 9, 1998 ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride CAPSULE;ORAL 020885-002 Oct 9, 1998 ⤷  Try a Trial ⤷  Try a Trial
Apotex PAXIL paroxetine hydrochloride TABLET;ORAL 020031-003 Dec 29, 1992 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PAXIL

See the table below for patents covering PAXIL around the world.

Country Patent Number Title Estimated Expiration
Sweden 521084 Förfarande för framställning av paroxetin-hydroklorid- anhydrat från ett paroxetin-hydroklorid-solvat ⤷  Try a Trial
Spain 2209428 ⤷  Try a Trial
Canada 2211521 ⤷  Try a Trial
Switzerland 688353 Formen von Paroxetin-Hydrochlorid. ⤷  Try a Trial
European Patent Office 0734260 COMPRIMES DE PAROXETINE ET LEUR PROCEDE DE PREPARATION (PAROXETINE TABLETS AND PROCESS TO PREPARE THEM) ⤷  Try a Trial
World Intellectual Property Organization (WIPO) 9516448 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.